Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact
Active, not recruiting Not applicable

Effect of Time-restricted Eating and Endurance Training on Markers of the Health of Women and Men

NCT05229835 · tracked via the Priya Life Science Poland tracker
Phase
Not applicable
Started
2022-01-20
Last updated
2023-07-24

Condition(s) studied

Physical ExerciseTime Restricted EatingMental Health Wellness 1WellbeingBiochemical Markers

Investigational drug(s) / intervention(s)

Time restricted eating and exercise

Time restricted eating and exercise: We apply time restricted eating, exercise alone and combined

Study summary

The aim of this project is to demonstrate the synergistic effect of TRE and NW training on health indicators for older women. The women will be divided into four groups, i.e. Control group (CG); time-restricted eating group (TRG) which will follow 12 weeks of TRE protocol; Nordic walking training group (NWT) which will follow 12 weeks of supervised Nordic walking training and Nordic walking training combined with a time-restricted eating group (NW-TRG). In addition, it is assumed to prove that among young men, TRE will improve adaptation to endurance training and improve the metabolism. The study will be divided into two groups: 1. a group undergoing endurance training and 2. a group combining endurance training with TRE. In all subject's changes in the metabolism of iron, tryptophan, vitamin D and lipids will be evaluated. Endocrine function of skeletal muscles, mental state and cognitive abilities of the subjects will also be examined. The investigators expect that the applied procedure of temporary restriction of food intake will be easy to apply and continue for much longer than the study period. In order to maintain this time window, test subjects will be asked to delay their breakfast and early dinner intake. In addition, it is expected that the improvement in wellbeing, vitality and a significant improvement in performance and biochemical indicators of health, especially in the NWT plus TRE group, will allow to better understand the physiology of exercise, which may result in future specific health recommendations for people of different ages.

Eligibility

Sex
ALL
Min age
20 Years
Max age
85 Years
Healthy volunteers
Accepted
Inclusion Criteria: * medical checkup * good health status Exclusion Criteria: * acute cardiovascular disease * acute respiratory disease * stable hypertension, * blood pressure over 160/100 mmHg * pregnancy

Primary outcome measure(s)

  • Time restricted eating and physical performance — 12 weeks
    The impact of this procedure on physical performance
  • Time restricted eating and mental performance — 12 weeks
    The impact of this procedure on mental performance
  • Time restricted eating and iron metabolism — 12 weeks
    The impact of this procedure on iron metabolism
  • Time restricted eating and myokines concentration — 12 weeks
    The impact of this procedure on myokinins concentration
  • Time restricted eating and lipid metabolism — 12 weeks
    The impact of this procedure on lipid metabolism
  • Time restricted eating and glucose metabolism — 12 weeks
    The impact of this procedure on glucose metabolism
  • Time restricted eating and tryptophan metabolism — 12 weeks
    The impact of this procedure on tryptophan metabolism
  • Time restricted eating and vitamin D metabolism — 12 weeks
    The impact of this procedure on vitamin D metabolism

Trial sites (1)

FacilityCityRegionStatus
Medical University of Gdańsk Faculty of Health Science Gdansk Pomeranian Voivodeship
Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT05229835 on ClinicalTrials.gov ↗ ← All trials in Poland